Search

Your search keyword '"Myositis -- Drug therapy"' showing total 1 results
Start Over Descriptor "Myositis -- Drug therapy" Journal legal monitor worldwide

Refine your results

1 results on '"Myositis -- Drug therapy"'

1. Orphazymes arimoclomol receives US Fast Track designation in sporadic Inclusion Body Myositis

Subjects
United States. Food and Drug Administration, Myositis -- Drug therapy, Shock, Business, international, Law
Abstract

Orphazyme A/S (ORPHA.CO), a biopharmaceutical company pioneering Heat-Shock Protein response for the treatment of neurodegenerative orphan diseases, today received Fast Track designation from the US Food and Drug Administration (FDA) [...]

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results